These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 13292783)

  • 1. Treatment of peripheral vascular disease with cyclospasmol.
    GILLHESPY RO
    Angiology; 1956 Feb; 7(1):27-31. PubMed ID: 13292783
    [No Abstract]   [Full Text] [Related]  

  • 2. The treatment of peripheral vascular diseases with cyclospasmol (mandelic acid ester of 3, 5, 5-trimethylcyclohexanol).
    VAN WIJK TW
    Angiology; 1953 Apr; 4(2):103-13. PubMed ID: 13040814
    [No Abstract]   [Full Text] [Related]  

  • 3. Vasodilators and the use of cyclospasmol in peripheral vascular disease.
    MAHL MM
    Angiology; 1961 Sep; 12():432-4. PubMed ID: 13765381
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cyclospasmol therapy of ulcus cruris].
    REEDER JM
    Geneeskd Gids; 1953 Aug; 31(17):370-1. PubMed ID: 13095699
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypertensive angina treated with cyclospasmol; report on a case.
    BARRETT CT
    S Afr Med J; 1952 Sep; 26(36):734. PubMed ID: 13005025
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of cyclandelate (cyclospasmol) in treatment of circulatory disturbances.
    LESLIE RE
    Tex State J Med; 1960 May; 56():352-6. PubMed ID: 14415999
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic activity of cyclospasmol (3,5,5-trimethylcyclohexanol mandelic ester) in coronary & peripheral vascular diseases; casuistic contribution].
    BALLERINI C; FIORE G
    Gazz Med Ital; 1959 Apr; 118(4):136-41. PubMed ID: 13664047
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of a product of esterification of mandelic acid with 3,5,5-triethylcyclohexanol (cyclospasmol) in the treatment of peripheral arteriopathy].
    STARACE G; NOFERI A; PADULA R
    Gazz Med Ital; 1960 Apr; 119():133-6. PubMed ID: 13833815
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diagnosis and treatment of peripheral vascular diseases; experience with cyclospasmol].
    NIEVEEN J; RODBARD JA; VAN WIJK TW
    Ned Tijdschr Geneeskd; 1954 Jan; 98(4):205-16. PubMed ID: 13144906
    [No Abstract]   [Full Text] [Related]  

  • 10. [Value of high doses of amygdalic ester of 3,5,5-trimethylcyclohexanol (cyclospasmol) in the treatment of peripheral vascular disorders].
    MATHIEU L; PERNOT C; METZ J; STREIFF F
    Rev Med Nancy; 1959 Mar; 84():255-67. PubMed ID: 13646365
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of peripheral vascular diseases with tocopheral and with eupaverin].
    FERABOLI PC
    Gazz Med Ital; 1952 Nov; 111(11):285-8. PubMed ID: 13043798
    [No Abstract]   [Full Text] [Related]  

  • 12. The pharmacology of cyclospasmol.
    BIJLSMA UG; FUNCKE AB; TERSTEEGE HM; REKKER RF; ERNSTING MJ; NAUTA WT
    Arch Int Pharmacodyn Ther; 1956 Feb; 105(1-2):145-74. PubMed ID: 13314726
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cyclospasmol (mandelic acid ester of 3,5,5-trimethylcyclohexanol) in therapy of skin diseases].
    DOORNINK FJ
    Geneeskd Gids; 1953 Jun; 31(12):247-51. PubMed ID: 13083900
    [No Abstract]   [Full Text] [Related]  

  • 14. Investigation into 3.5.5-trimethylcyclohexyl mandelate cyclospasmol.
    EIJKEL G; ERNSTING MJ; REKKER RF; NAUTA WT
    Pharm Weekbl; 1956 May; 91(10):349-58. PubMed ID: 13335486
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of disorders of the peripheral circulation by the amygdalic ester of 3,5,5-trimethylcyclohexanol].
    RAVINA A
    Presse Med (1893); 1960 Jun; 68():1240-2. PubMed ID: 14436571
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical experience with tensodin, a vasodilator.
    SAMUELS SS
    N Y State J Med; 1956 Jun; 56(11):1804-7. PubMed ID: 13322275
    [No Abstract]   [Full Text] [Related]  

  • 17. The melting-point of cyclospasmol and the quantitative determination of small amounts of 3.5.5.-trimethylcyclohexyl phenylglyoxylate in same.
    REKKER RF; ERNSTING MJ; NAUTA WT
    Pharm Weekbl; 1956 Jan; 91(1):1-6. PubMed ID: 13310216
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical experiences with isoxsuprine.
    CLARKSON IS; LE PERE DM
    Angiology; 1960 Jun; 11():190-2. PubMed ID: 13810525
    [No Abstract]   [Full Text] [Related]  

  • 19. Investigation into 3.5.5-trimethylcyclohexyl mandelate (cyclospasmol).
    EIJKEL G; ERNSTING MJ; REKKER RF; NAUTA WT
    Pharm Weekbl; 1956 Feb; 91(3):81-90. PubMed ID: 13310218
    [No Abstract]   [Full Text] [Related]  

  • 20. A clinical study of a musculotropic vasodilating compound.
    SHAFTEL HE; SAMUELS S; PADERNACHT E
    Angiology; 1961 Sep; 12():423-6. PubMed ID: 13750570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.